Mounjaro

Mounjaro is most effective when combined with a balanced diet and regular movement, such as walking, swimming, or cycling. The medication helps regulate appetite and blood sugar, which can make lifestyle changes easier to sustain. Working with a healthcare professional or dietitian can help tailor these habits for long-term success. Why lifestyle still matters NICE and NHS guidance emphasise that Mounjaro should always be used alongside lifestyle modification. The medicine he

Most people notice reduced appetite and better blood sugar levels within the first few weeks of starting Mounjaro. Visible weight loss tends to appear more gradually, often becoming noticeable after two to three months of consistent use. Long-term results are typically seen over several months as the medication supports steady, manageable progress. What happens in the first few weeks NICE and NHS guidance describe Mounjaro’s early effects as a period of “metabolic adjustment.

Mounjaro is usually taken once a week by injection under the skin, on the same day each week. Treatment often begins with a 2.5 mg dose for four weeks, before gradually increasing to higher doses like 5 mg, 10 mg, or 15 mg. This step-up approach helps your body adjust and reduces the likelihood of side effects such as nausea. How the weekly routine works Mounjaro (tirzepatide) comes in a pre-filled, single-use injection pen designed for once-weekly administration. NICE (TA102

Yes — several large clinical trials, including the SURPASS and SURMOUNT studies, have shown that Mounjaro significantly lowers blood sugar and supports weight loss in adults with or without type 2 diabetes. In some trials, participants lost over 20 % of their body weight, depending on dose and duration. These results were published in respected medical journals and reviewed by agencies such as the MHRA and NICE. The major trials behind Mounjaro The key research programmes tha

Most other weight-loss injections, like semaglutide (used in Wegovy), act only on the GLP-1 receptor. Mounjaro’s dual action on GIP and GLP-1 sets it apart, giving it a broader effect on metabolism and appetite regulation. Clinical studies suggest this combination may lead to greater improvements in blood sugar and weight, though results vary from person to person. Understanding the difference in how they work Both Mounjaro and Wegovy belong to a class of medicines known as i

Mounjaro targets two key hormone receptors in the body — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These hormones help regulate blood sugar, appetite, and energy use. By acting on both, Mounjaro improves how your body handles glucose while also curbing hunger, helping support steady, sustainable weight loss. How the GIP and GLP-1 hormones work Both GIP and GLP-1 are naturally released from the gut after eating. They signal the pan

The active ingredient in Mounjaro is tirzepatide, a man-made version of two natural hormones called GIP and GLP-1. These hormones help regulate blood sugar and appetite, so tirzepatide works by enhancing your body’s own ability to manage these processes. What makes Mounjaro unique is that it targets both hormone pathways at once, which is thought to contribute to its effects on blood sugar control and weight management. Understanding how tirzepatide works in the body Tirzepat

The vast majority of patients on Mounjaro currently pay for it privately but some patients can get it on the NHS...

Nausea? Hair loss? Headaches Acid reflux? Sulphur burps? These can be some of the most common side effects when using weight loss medications such as Mounjaro and Wegovy. We can help.

Wegovy is taken once weekly via an injection pen, with doses stepped up over 16 weeks. Saxenda requires a daily injection, Mounjaro is a...

On the NHS, costs are set through commercial arrangements and are not always public, while in private practice the listed prices for...

Choosing between Wegovy and Mounjaro comes down to what you’re aiming for (weight, blood sugar, side-effect profile) and what’s available to you. Many people see strong results with both; tirzepatide can yield greater reductions for some, while semaglutide has a longer real-world track record. Why these two drugs stand out Wegovy and Mounjaro are often compared because they’re part of the same family of treatments known as incretin-based medicines. Both act on hormones that h

Mounjaro (tirzepatide) and Wegovy (semaglutide) are both effective; some studies show larger average weight loss with tirzepatide, but individual response, side-effects, access, and clinical goals matter. The “better” choice is the one that fits your health needs and tolerability after a clinician review. Two medicines, two mechanisms Wegovy and Mounjaro both belong to a family of medicines that mimic natural gut hormones involved in appetite and metabolism. Wegovy contains s

You may have seen the news today... The price of ‘King Kong’ fat jab Mounjaro will almost triple from September adding a potential £2,704 a year to the cost of the drug.

Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. New weight loss pill...

"Only 8 out of 42 health boards are offering Mounjaro... so what's the hold up?" You've guessed it - Mounjaro is in the news again due to the latest controversy of the King-Kong weight loss jab being touted as 'available' on the NHS.... so what exactly is going on? Why are thousands of patients still waiting for a treatment that could transform their lives? Mounjaro was meant to be rolled out across the NHS in England from 23 June for those with the highest clinical need unde

Mounjaro , also known as tirzepatide, stays in your system for approximately 5 weeks after the last dose. The elimination half-life of...

Injecting Mounjaro  involves a few straightforward steps: selecting your injection site, preparing your pen, delivering the dose, and...

The duration of Mounjaro’s side effects can vary among individuals. Common side effects such as gastrointestinal issues (nausea,...

Mounjaro  is generally considered safe when prescribed by a healthcare provider who monitors its use. Clinical trials  and studies have...